Unlike rideshare apps that surge-price during Spurs games or Fiesta weekends, we maintain transparent pricing
Real World Impact: Current Use and Outcomes These medications are no longer niche, they're influencing population level trends: Rapid Growth in Use In the U.S., reported use of GLP-1 weight loss drugs has more than doubled in the past year, from about 5.8% of adults in early 2024 to over 12% in 2025 Women tend to use these medications at higher rates than men, with 15.2% vs
Peptide powders and vials sold by research chemical vendors are sold under a "for research purposes only" designation - not as consumer supplements, not with consumer return policies, not with manufacturing accountability under GMP standards, and not with third-party testing documentation comparable to what a regulated supplement brand provides
Funding The current research was funded by Vice Chancellor for Research at Ahvaz Jundishapur University of Medical Sciences and Pars Behrouzan Jam Company
A plasma free carnitine concentration of 20 mcmol/L or less, or a total carnitine concentration of 30 mcmol/L or less, is considered abnormally low [1]